Adjuvant atezolizumab after adjuvant chemotherapy in resected stage IB–IIIA non-small-cell lung cancer (IMpower010): a randomised, multicentre, open-label, phase 3 trialEnriqueta Felip, Heather A. Wakelee, Alex Martínez‐Martí et al.|The Lancet|2021Cited by 1.5k
IMpower010: Primary results of a phase III global study of atezolizumab versus best supportive care after adjuvant chemotherapy in resected stage IB-IIIA non-small cell lung cancer (NSCLC).Heather A. Wakelee, Enriqueta Felip, Nasser K. Altorki et al.|Journal of Clinical Oncology|2021Cited by 117
Large tumor suppressor homologs 1 and 2 regulate mouse liver progenitor cell proliferation and maturation through antagonism of the coactivators YAP and TAZJing Yi, Randy L. Johnson|Hepatology|2016Cited by 101
Endothelial SUR‐8 acts in an ERK‐independent pathway during atrioventricular cushion developmentJing Yi, Rener Xu|Developmental Dynamics|2010Cited by 37